Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Toxicology Letters
|
December 1, 1995
Physiologically based pharmacokinetic models applicable to organogenesis: extrapolation between species and potential use in prenatal toxicity risk assessments
F Welsch, G M Blumenthal, R B Conolly
Clinical and Translational Science
|
February 5, 2017
Leveraging Genomic Factors to Improve Benefit-Risk
R N Schuck, R Charlab, G M Blumenthal
Clinical Pharmacology and Therapeutics
|
January 12, 2017
Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing Science
G M Blumenthal, K B Goldberg, R Pazdur
Toxicology and Applied Pharmacology
|
November 14, 1997
A mathematical model of production, distribution, and metabolism of melatonin in mammalian systems
G M Blumenthal, M C Kohn, C J Portier
Toxicology and Applied Pharmacology
|
August 1, 1997
Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice
K W Ward, G M Blumenthal, F Welsch, et al.
Clinical Pharmacology and Therapeutics
|
April 19, 2017
Cancer Therapy: Shooting for the Moon
Jsh Lee, G M Blumenthal, R J Hohl, et al.
Seminars in Oncology
|
November 29, 2018
Age-related differences in patient-reported outcomes in patients with advanced lung cancer receiving anti-PD-1/PD-L1 therapy
B L King-Kallimanis, B Kanapuru, G M Blumenthal, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
August 1, 1995
Toxicokinetics of a single 50 mg/kg oral dose of [2,3-14C]acrylamide in White Leghorn hens
G M Blumenthal, A A Abdel-Rahman, K R Wilmarth, et al.
Toxicology and Applied Pharmacology
|
February 9, 2000
Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats
S M Hays, B A Elswick, G M Blumenthal, et al.
Clinical Pharmacology and Therapeutics
|
February 14, 2015
The role of nonrandomized trials in the evaluation of oncology drugs
R Simon, G M Blumenthal, M L Rothenberg, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Toxicology Letters
|
December 1, 1995
Physiologically based pharmacokinetic models applicable to organogenesis: extrapolation between species and potential use in prenatal toxicity risk assessments
F Welsch, G M Blumenthal, R B Conolly
Clinical and Translational Science
|
February 5, 2017
Leveraging Genomic Factors to Improve Benefit-Risk
R N Schuck, R Charlab, G M Blumenthal
Clinical Pharmacology and Therapeutics
|
January 12, 2017
Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing Science
G M Blumenthal, K B Goldberg, R Pazdur
Toxicology and Applied Pharmacology
|
November 14, 1997
A mathematical model of production, distribution, and metabolism of melatonin in mammalian systems
G M Blumenthal, M C Kohn, C J Portier
Toxicology and Applied Pharmacology
|
August 1, 1997
Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice
K W Ward, G M Blumenthal, F Welsch, et al.
Clinical Pharmacology and Therapeutics
|
April 19, 2017
Cancer Therapy: Shooting for the Moon
Jsh Lee, G M Blumenthal, R J Hohl, et al.
Seminars in Oncology
|
November 29, 2018
Age-related differences in patient-reported outcomes in patients with advanced lung cancer receiving anti-PD-1/PD-L1 therapy
B L King-Kallimanis, B Kanapuru, G M Blumenthal, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
August 1, 1995
Toxicokinetics of a single 50 mg/kg oral dose of [2,3-14C]acrylamide in White Leghorn hens
G M Blumenthal, A A Abdel-Rahman, K R Wilmarth, et al.
Toxicology and Applied Pharmacology
|
February 9, 2000
Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats
S M Hays, B A Elswick, G M Blumenthal, et al.
Clinical Pharmacology and Therapeutics
|
February 14, 2015
The role of nonrandomized trials in the evaluation of oncology drugs
R Simon, G M Blumenthal, M L Rothenberg, et al.
Page
of 2